Braeburn Pharmaceuticals has acquired a 6-month implant of antipsychotic drug risperidone from Endo Pharmaceuticals. The drug, whose brand name is Risperdal, is used to treat patients with bipolar disorder and schizophrenia, though it has also been administered to treat symptoms of ADHD, particularly in young children.
Risperdal requires daily administration for effectiveness, which the implant covers for 6 months. However, the drug has been linked to a risk of serious side effects with prolonged use, including gynecomastia, or breast tissue growth, among boys and male adolescents.
Studies have found that Risperdal could lead to an increased level of prolactin, the hormone responsible for breast tissue growth. Drug manufacturer Janssen Pharmaceuticals faces multiple Risperdal lawsuits alleging that the drug caused breast tissue growth in young men. Recently, a 20-year old Alabama man was awarded $2.5 million after the drug caused him to develop breasts over an 8-year period of using the drug.
Filing a Risperdal Lawsuit
If you or a loved one experienced breast growth after taking Risperdal, you may be eligible to file a lawsuit. Contact the Risperdal lawyers at Hissey Kientz, LLP for a free case evaluation. You can reach us by calling toll-free at 1-866-275-4454, or by filling out our free contact form.